George Sopko
NHLBI, United States
Dr. Sopko plans, develops, directs, coordinates, and conducts basic, applied, and clinical research in cardiovascular disease. He has responsibility for promoting efforts to enhance understanding of the etiology and pathophysiology of heart disease; to improve its methods of diagnosis, treatment and prevention; to participate in developing policy and prioritization regarding pioneering research programs, both domestic and international, to meet national needs. He served as the Program or Deputy Program Director for many NIH-supported clinical studies, notably Catheter Ablation Registry (CAR), Thrombolysis In Myocardial Infarction (TIMI II), Coronary Artery Surgery Study (CASS), Bypass Angioplasty Revascularization Investigation (BARI), Women’s Ischemic Syndrome Evaluation (WISE1 and WISE2), Occluded Artery Trial (OAT), Surgical Treatment of Congestive Heart Failure (STICH), Resuscitation Outcomes Consortium (ROC), SIREN (Strategies to Innovate EmeRgENcy Care Clinical Trials). Dr. Sopko has served on multiple NIH task forces and panels and co-chaired a number of workshop/working groups, served as the NIH or NHLBI representative, and has received a number of awards.
